Edgewell Personal Care Company (EPC) 10-Year Financial Performance & Capital Metrics

EPC •

Consumer DefensiveHousehold ProductsPersonal Care and Beauty Products

AboutEdgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide. It operates through three segments: Wet shave, Sun and Skin care, and Feminine care. The Wet Shave segment provides razor systems, such as razor handles and refillable blades, and disposable shave products for men and women under the Schick, Wilkinson Sword, Edge, Skintimate, Shave Guard, and Personna brands. The Sun and Skin Care segment provides general protection, sport, kids, baby, tanning and after sun products under the Banana Boat and Hawaiian Tropic brands, as well as antibacterial hand wipes, alcohol sanitizing wipes, and hand sanitizer gels under the Wet Ones brand; and skin care products for men under the Bulldog and Jack Black brands, and skin care and grooming products under the Cremo brand. The Feminine Care segment provides tampons under the Playtex Gentle Glide 360°, Playtex Sport, Playtex and o.b. brands; and markets pads and liners under the Stayfree and Carefree brands. The company was formerly known as Energizer Holdings, Inc. and changed its name to Edgewell Personal Care Company in June 2015. Edgewell Personal Care Company was founded in 1772 and is headquartered in Shelton, Connecticut.Show more

Revenue $2.22B -1.3%
EBITDA $185M -35.5%
Net Income $25M -74.2%
EPS (Diluted) 0.53 -73.1%
Gross Margin 41.6% -1.9%
EBITDA Margin 8.34% -34.6%
Operating Margin 4.34% -50.9%
Net Margin 1.14% -73.9%
ROE 1.62% -74.3%
ROIC 2.57% -52.4%
Debt/Equity 0.99 +13.5%
Interest Coverage 1.32 -49.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 2.7%
✓Share count reduced 5.0% through buybacks
✓Trading at only 0.7x book value

✗Weaknesses

✗Profits declining 17.8% over 5 years
✗Dividend payout exceeds 100% of earnings
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-0.85%

5Y2.66%

3Y0.79%

TTM-3.36%

Profit (Net Income) CAGR

10Y-

5Y-17.78%

3Y-36.56%

TTM-141.66%

EPS CAGR

10Y-

5Y-15.63%

3Y-34.2%

TTM-146.82%

ROCE

10Y Avg6.97%

5Y Avg5.99%

3Y Avg5.46%

Latest3.04%

Peer Comparison

Personal Care and Beauty Products

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
DSYBig Tree Cloud Holdings Limited	178.66M	3.13	254.47	16.37%	-4.42%	2.43%
AXILAXIL Brands, Inc.	46.22M	6.80	67.95	-4.51%	4.95%	12.37%	3.32%	0.08
ELFe.l.f. Beauty, Inc.	5.13B	92.05	47.94	28.28%	6.84%	8.95%	2.25%	0.41
EPCEdgewell Personal Care Company	1.06B	22.74	42.91	-1.34%	-1.76%	-2.57%	3.9%	0.99
CLColgate-Palmolive Company	79.91B	99.14	37.70	1.4%	10.46%	5.84%	4.55%	21.88
IPARInter Parfums, Inc.	3.23B	100.78	19.68	10.22%	11.24%	14.9%	5.66%	0.20
SLSNSolesence, Inc. Common Stock	90.29M	1.28	18.29	40.35%	1.72%	6.21%		1.02
COTYCoty Inc.	2.19B	2.51	-5.70	-3.68%	-9.19%	-14.39%	12.68%	1.07

Profit & Loss

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Sales/Revenue+	2.36B	2.3B	2.23B	2.14B	1.95B	2.09B	2.17B	2.25B	2.25B	2.22B
Revenue Growth %	-2.45%	-2.69%	-2.78%	-4.18%	-8.94%	7.06%	4.04%	3.68%	0.09%	-1.34%
Cost of Goods Sold+	1.2B	1.17B	1.2B	1.17B	1.07B	1.14B	1.29B	1.31B	1.3B	1.3B
COGS % of Revenue	50.89%	51.01%	53.77%	54.85%	54.82%	54.43%	59.46%	58.22%	57.59%	58.4%
Gross Profit+	1.16B	1.13B	1.03B	966.6M	880.9M	951.2M	880.5M	940.8M	955.7M	924.9M
Gross Margin %	49.11%	48.99%	46.23%	45.15%	45.18%	45.57%	40.54%	41.78%	42.41%	41.6%
Gross Profit Growth %	-2.02%	-2.93%	-8.26%	-6.42%	-8.87%	7.98%	-7.43%	6.85%	1.58%	-3.22%
Operating Expenses+	1.16B	1.13B	1.03B	722.8M	704.9M	711.3M	698.2M	713.8M	756.4M	828.3M
OpEx % of Revenue	49.11%	48.99%	46.23%	33.76%	36.15%	34.08%	32.15%	31.7%	33.56%	37.25%
Selling, General & Admin	749.4M	710.8M	688.4M	622.9M	625M	632.7M	627.4M	638.7M	662.1M	671.7M
SG&A % of Revenue	31.73%	30.93%	30.81%	29.09%	32.06%	30.31%	28.89%	28.37%	29.38%	30.21%
Research & Development	71.9M	67.6M	61.1M	53.5M	55.3M	57.8M	55.5M	58.5M	58.4M	57.6M
R&D % of Revenue	3.04%	2.94%	2.73%	2.5%	2.84%	2.77%	2.56%	2.6%	2.59%	2.59%
Other Operating Expenses	338.6M	347.5M	283.4M	46.4M	24.6M	20.8M	15.3M	16.6M	35.9M	99M
Operating Income+	338.6M	347.5M	283.4M	243.8M	176M	239.9M	182.3M	227M	199.3M	96.6M
Operating Margin %	14.34%	15.12%	12.68%	11.39%	9.03%	11.49%	8.39%	10.08%	8.84%	4.34%
Operating Income Growth %	94.49%	2.63%	-18.45%	-13.97%	-27.81%	36.31%	-24.01%	24.52%	-12.2%	-51.53%
EBITDA+	431.2M	441.9M	381M	337.6M	264.8M	327M	272.2M	318.4M	287.3M	185.4M
EBITDA Margin %	18.26%	19.23%	17.05%	15.77%	13.58%	15.67%	12.53%	14.14%	12.75%	8.34%
EBITDA Growth %	49%	2.48%	-13.78%	-11.39%	-21.56%	23.49%	-16.76%	16.97%	-9.77%	-35.47%
D&A (Non-Cash Add-back)	92.6M	94.4M	97.6M	93.8M	88.8M	87.1M	89.9M	91.4M	88M	88.8M
EBIT	291.7M	16.3M	231.8M	-327.7M	148.5M	215M	195.5M	226.2M	197.4M	96.8M
Net Interest Income+	-71.8M	-69.2M	-68M	-62.6M	-61.2M	-67.9M	-71.4M	-78.5M	-76.5M	-73.2M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	71.8M	69.2M	68M	62.6M	61.2M	67.9M	71.4M	78.5M	76.5M	73.2M
Other Income/Expense	-118.7M	-400.4M	-119.6M	-634.1M	-88.7M	-92.8M	-58.2M	-79.3M	-78.4M	-73M
Pretax Income+	219.9M	-52.9M	163.8M	-390.3M	87.3M	147.1M	124.1M	147.7M	120.9M	23.6M
Pretax Margin %	9.31%	-2.3%	7.33%	-18.23%	4.48%	7.05%	5.71%	6.56%	5.36%	1.06%
Income Tax+	41.2M	-58.6M	60.5M	-18.1M	19.7M	29.3M	24.6M	33M	22.3M	-1.8M
Effective Tax Rate %	81.26%	-10.78%	63.06%	95.36%	77.43%	80.08%	80.18%	77.66%	81.56%	107.63%
Net Income+	178.7M	5.7M	103.3M	-372.2M	67.6M	117.8M	99.5M	114.7M	98.6M	25.4M
Net Margin %	7.57%	0.25%	4.62%	-17.38%	3.47%	5.64%	4.58%	5.09%	4.38%	1.14%
Net Income Growth %	164.91%	-96.81%	1712.28%	-460.31%	118.16%	74.26%	-15.53%	15.28%	-14.04%	-74.24%
Net Income (Continuing)	178.7M	5.7M	103.3M	-372.2M	67.6M	117.8M	99.5M	114.7M	98.6M	25.4M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	2.99	0.10	1.90	-6.52	1.24	2.12	1.86	2.21	1.97	0.53
EPS Growth %	167.34%	-96.66%	1800%	-443.16%	119.02%	70.97%	-12.26%	18.82%	-10.86%	-73.1%
EPS (Basic)	3.02	0.10	1.90	-6.52	1.25	2.15	1.87	2.24	1.98	0.53
Diluted Shares Outstanding	59.7M	57.5M	54.5M	54.1M	54.6M	55.2M	53.6M	51.8M	50.1M	47.6M
Basic Shares Outstanding	59.2M	57.3M	54.4M	54.1M	54.3M	54.4M	53.1M	51.2M	49.7M	47.5M
Dividend Payout Ratio	-	-	-	-	-	21.73%	32.76%	27.46%	31.14%	115.35%

Balance Sheet

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Current Assets+	1.45B	1.19B	951.2M	1.04B	983.6M	1.14B	942.2M	962.4M	936M	995.5M
Cash & Short-Term Investments	738.9M	502.9M	266.4M	341.6M	364.7M	479.2M	188.7M	216.4M	209.1M	225.7M
Cash Only	738.9M	502.9M	266.4M	341.6M	364.7M	479.2M	188.7M	216.4M	209.1M	225.7M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	289.8M	241M	239.1M	205.6M	229.8M	230.6M	208.9M	168.8M	164.1M	194.8M
Days Sales Outstanding	44.78	38.27	39.06	35.05	43.02	40.32	35.11	27.36	26.58	31.98
Inventory	309.2M	333.5M	329.5M	357.2M	314.1M	345.7M	449.3M	492.4M	477.3M	484.7M
Days Inventory Outstanding	93.88	103.82	100.1	111.02	107.27	111.06	127.01	137.11	134.22	136.24
Other Current Assets	94.2M	70.1M	60.4M	75M	10.2M	12.9M	25.1M	12.3M	9.1M	11.9M
Total Non-Current Assets+	3.32B	3B	3B	2.4B	2.56B	2.54B	2.77B	2.78B	2.79B	2.76B
Property, Plant & Equipment	486.1M	453.4M	424.1M	396M	414.4M	362.6M	345.5M	337.9M	434.5M	369.3M
Fixed Asset Turnover	4.86x	5.07x	5.27x	5.41x	4.70x	5.76x	6.29x	6.66x	5.19x	6.02x
Goodwill	1.42B	1.45B	1.45B	1.05B	1.16B	1.16B	1.32B	1.33B	1.34B	1.29B
Intangible Assets	1.39B	1.07B	1.1B	912.9M	928.1M	906.4M	996.7M	973.8M	948.5M	921.3M
Long-Term Investments	-255.3M	-181.8M	-176.1M	-101.1M	0	0	0	0	0	0
Other Non-Current Assets	28M	31.6M	28.2M	34.8M	55.1M	107.1M	106.6M	135.2M	73.3M	179.1M
Total Assets+	4.77B	4.19B	3.95B	3.44B	3.54B	3.67B	3.71B	3.74B	3.73B	3.76B
Asset Turnover	0.50x	0.55x	0.57x	0.62x	0.55x	0.57x	0.58x	0.60x	0.60x	0.59x
Asset Growth %	-4.41%	-12.21%	-5.62%	-12.94%	2.88%	3.78%	1.05%	0.74%	-0.26%	0.68%
Total Current Liabilities+	868.2M	524.4M	717M	659.6M	510.5M	536.8M	539.5M	523.4M	563.6M	565.5M
Accounts Payable	196.5M	223.6M	238.4M	222.8M	181.9M	209.5M	228.8M	194.4M	219.3M	219.7M
Days Payables Outstanding	59.66	69.61	72.42	69.25	62.12	67.31	64.68	54.13	61.67	61.75
Short-Term Debt	300.3M	19.4M	193.1M	131.4M	30.2M	26.5M	19M	19.5M	41.2M	44.9M
Deferred Revenue (Current)	0	0	24.3M	1.7M	1.4M	600K	1.1M	0	1.1M	800K
Other Current Liabilities	269.6M	222.5M	214.7M	230.3M	215.1M	132.4M	122.3M	131.9M	209.8M	226.7M
Current Ratio	1.67x	2.26x	1.33x	1.58x	1.93x	2.12x	1.75x	1.84x	1.66x	1.76x
Quick Ratio	1.32x	1.63x	0.87x	1.04x	1.31x	1.47x	0.91x	0.90x	0.81x	0.90x
Cash Conversion Cycle	79	72.48	66.73	76.82	88.17	84.08	97.44	110.34	99.13	106.46
Total Non-Current Liabilities+	2.07B	1.92B	1.49B	1.46B	1.6B	1.55B	1.71B	1.68B	1.58B	1.64B
Long-Term Debt	1.54B	1.53B	1.1B	1.1B	1.24B	1.23B	1.39B	1.36B	1.27B	1.44B
Capital Lease Obligations	0	0	0	0	34.6M	46.9M	41.5M	53.9M	69.8M	57.1M
Deferred Tax Liabilities	255.3M	181.8M	176.1M	102.8M	124.3M	129M	140.4M	136.4M	149.8M	130M
Other Non-Current Liabilities	274.8M	397.3M	387.9M	258.9M	200.7M	143.4M	133.2M	125.8M	88.6M	10.2M
Total Liabilities	2.94B	2.45B	2.21B	2.12B	2.11B	2.09B	2.25B	2.2B	2.15B	2.2B
Total Debt+	1.84B	1.54B	1.3B	1.23B	1.3B	1.32B	1.46B	1.45B	1.39B	1.54B
Net Debt	1.11B	1.04B	1.03B	887.6M	938M	839.4M	1.27B	1.23B	1.18B	1.32B
Debt / Equity	1.01x	0.89x	0.74x	0.93x	0.91x	0.83x	1.00x	0.94x	0.87x	0.99x
Debt / EBITDA	4.28x	3.50x	3.40x	3.64x	4.92x	4.03x	5.37x	4.55x	4.82x	8.32x
Net Debt / EBITDA	2.56x	2.36x	2.70x	2.63x	3.54x	2.57x	4.67x	3.87x	4.10x	7.10x
Interest Coverage	4.72x	5.02x	4.17x	3.89x	2.88x	3.53x	2.55x	2.89x	2.61x	1.32x
Total Equity+	1.83B	1.74B	1.74B	1.32B	1.43B	1.58B	1.47B	1.54B	1.58B	1.55B
Equity Growth %	-1.88%	-4.77%	0.17%	-24.18%	8.32%	10.57%	-7.4%	5%	2.83%	-1.96%
Book Value per Share	30.64	30.29	32.01	24.45	26.24	28.70	27.37	29.74	31.62	32.63
Total Shareholders' Equity	1.83B	1.74B	1.74B	1.32B	1.43B	1.58B	1.47B	1.54B	1.58B	1.55B
Common Stock	700K	700K	700K	700K	700K	700K	700K	700K	700K	700K
Retained Earnings	946M	952.9M	1.08B	734.1M	782.4M	865.7M	939.1M	1.02B	1.09B	1.09B
Treasury Stock	-563M	-703.9M	-819.2M	-803.8M	-790.4M	-776.3M	-860.9M	-906.1M	-937.9M	-1B
Accumulated OCI	-197.2M	-131.4M	-148.3M	-235.9M	-191.6M	-136.9M	-216.1M	-170M	-154.8M	-109.8M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Cash from Operations+	176.4M	296.2M	264.7M	190.6M	232.6M	229M	102M	216.1M	231M	118.4M
Operating CF Margin %	7.47%	12.89%	11.85%	8.9%	11.93%	10.97%	4.7%	9.6%	10.25%	5.32%
Operating CF Growth %	18.55%	67.91%	-10.63%	-27.99%	22.04%	-1.55%	-55.46%	111.86%	6.89%	-48.74%
Net Income	178.7M	5.7M	103.3M	-352.9M	67.6M	117.8M	99.5M	114.7M	98.6M	25.4M
Depreciation & Amortization	92.6M	94.4M	97.6M	93.8M	88.8M	87.1M	89.9M	91.4M	88M	88.8M
Stock-Based Compensation	25.6M	22.2M	17M	17.8M	19.2M	27.3M	23.8M	27.5M	26.5M	24.5M
Deferred Taxes	7.8M	-87.4M	2.3M	-57.9M	-2.9M	9.6M	-13.7M	-4.5M	-9.6M	-21.7M
Other Non-Cash Items	-109.8M	282M	43.4M	537.3M	16.7M	15.2M	-15.4M	-18M	-20.1M	27.2M
Working Capital Changes	-18.5M	-20.7M	1.1M	-47.5M	43.2M	-28M	-82.1M	5M	47.6M	-25.8M
Change in Receivables	23.3M	41.4M	-5.4M	-1.9M	66.3M	3.7M	-6.6M	31M	-7.3M	-15.3M
Change in Inventory	28.2M	-15.5M	-12.3M	-35M	37.1M	-28.8M	-111.3M	-32.4M	19.7M	100K
Change in Payables	-29.3M	23.7M	11.5M	-15.1M	-42.9M	24.3M	29.3M	-30.2M	17M	3.3M
Cash from Investing+	-69.5M	-84.6M	-128.5M	-45.5M	-196.4M	-48.7M	-355.4M	-50.5M	-62.4M	-72.9M
Capital Expenditures	-69.5M	-69M	-62M	-58M	-47.7M	-56.8M	-56.4M	-49.5M	-56.5M	-77M
CapEx % of Revenue	2.94%	3%	2.77%	2.71%	2.45%	2.72%	2.6%	2.2%	2.51%	3.46%
Acquisitions	0	-34M	-71.2M	4.1M	-137.8M	7.2M	-304.4M	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	18.4M	4.7M	8.4M	2.9M	900K	5.4M	-1M	-5.9M	4.1M
Cash from Financing+	-83M	-460.6M	-375.2M	-63.8M	-18.7M	-65.4M	-17.6M	-146.5M	-179.4M	-30M
Debt Issued (Net)	114.2M	-295M	-247.7M	-69.2M	9.8M	-21.9M	151.1M	-33M	-83.8M	111.5M
Equity Issued (Net)	-1000K	-1000K	-1000K	0	0	-1000K	-1000K	-1000K	-1000K	-1000K
Dividends Paid	0	0	0	0	0	-25.6M	-32.6M	-31.5M	-30.7M	-29.3M
Share Repurchases	-196.6M	-165.4M	-124.4M	-3M	0	-9.2M	-125.3M	-75.2M	-58.5M	-90.2M
Other Financing	9.8M	-200K	-7.5M	5.4M	-28.5M	-8.7M	-10.8M	-6.8M	-6.4M	-22M
Net Change in Cash	26.8M	-236M	-236.5M	75.2M	23.1M	114.5M	-290.5M	27.7M	-7.3M	16.6M
Free Cash Flow+	106.9M	227.2M	202.7M	132.6M	184.9M	172.2M	45.6M	166.6M	174.5M	41.4M
FCF Margin %	4.53%	9.89%	9.07%	6.19%	9.48%	8.25%	2.1%	7.4%	7.74%	1.86%
FCF Growth %	116.4%	112.54%	-10.78%	-34.58%	39.44%	-6.87%	-73.52%	265.35%	4.74%	-76.28%
FCF per Share	1.79	3.95	3.72	2.45	3.39	3.12	0.85	3.22	3.48	0.87
FCF Conversion (FCF/Net Income)	0.99x	51.96x	2.56x	-0.51x	3.44x	1.94x	1.03x	1.88x	2.34x	4.66x
Interest Paid	71.3M	66.4M	66.6M	60.6M	56.1M	0	68.4M	74.3M	62.8M	0
Taxes Paid	28.3M	14.4M	22M	58M	24.6M	25.4M	23.8M	45.8M	33.5M	25.5M

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	9.68%	0.32%	5.93%	-24.27%	4.91%	7.81%	6.52%	7.63%	6.31%	1.62%
Return on Invested Capital (ROIC)	8.74%	9.12%	7.65%	7.34%	5.76%	7.51%	5.3%	6.18%	5.4%	2.57%
Gross Margin	49.11%	48.99%	46.23%	45.15%	45.18%	45.57%	40.54%	41.78%	42.41%	41.6%
Net Margin	7.57%	0.25%	4.62%	-17.38%	3.47%	5.64%	4.58%	5.09%	4.38%	1.14%
Debt / Equity	1.01x	0.89x	0.74x	0.93x	0.91x	0.83x	1.00x	0.94x	0.87x	0.99x
Interest Coverage	4.72x	5.02x	4.17x	3.89x	2.88x	3.53x	2.55x	2.89x	2.61x	1.32x
FCF Conversion	0.99x	51.96x	2.56x	-0.51x	3.44x	1.94x	1.03x	1.88x	2.34x	4.66x
Revenue Growth	-2.45%	-2.69%	-2.78%	-4.18%	-8.94%	7.06%	4.04%	3.68%	0.09%	-1.34%

US Stock Screener

...

Edgewell Personal Care Company (EPC) 10-Year Financial Performance & Capital Metrics

EPC •

Consumer DefensiveHousehold ProductsPersonal Care and Beauty Products

Revenue $2.22B -1.3%
EBITDA $185M -35.5%
Net Income $25M -74.2%
EPS (Diluted) 0.53 -73.1%
Gross Margin 41.6% -1.9%
EBITDA Margin 8.34% -34.6%
Operating Margin 4.34% -50.9%
Net Margin 1.14% -73.9%
ROE 1.62% -74.3%
ROIC 2.57% -52.4%
Debt/Equity 0.99 +13.5%
Interest Coverage 1.32 -49.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 2.7%
✓Share count reduced 5.0% through buybacks
✓Trading at only 0.7x book value

✗Weaknesses

✗Profits declining 17.8% over 5 years
✗Dividend payout exceeds 100% of earnings
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-0.85%

5Y2.66%

3Y0.79%

TTM-3.36%

Profit (Net Income) CAGR

10Y-

5Y-17.78%

3Y-36.56%

TTM-141.66%

EPS CAGR

10Y-

5Y-15.63%

3Y-34.2%

TTM-146.82%

ROCE

10Y Avg6.97%

5Y Avg5.99%

3Y Avg5.46%

Latest3.04%

Peer Comparison

Personal Care and Beauty Products

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
DSYBig Tree Cloud Holdings Limited	178.66M	3.13	254.47	16.37%	-4.42%	2.43%
AXILAXIL Brands, Inc.	46.22M	6.80	67.95	-4.51%	4.95%	12.37%	3.32%	0.08
ELFe.l.f. Beauty, Inc.	5.13B	92.05	47.94	28.28%	6.84%	8.95%	2.25%	0.41
EPCEdgewell Personal Care Company	1.06B	22.74	42.91	-1.34%	-1.76%	-2.57%	3.9%	0.99
CLColgate-Palmolive Company	79.91B	99.14	37.70	1.4%	10.46%	5.84%	4.55%	21.88
IPARInter Parfums, Inc.	3.23B	100.78	19.68	10.22%	11.24%	14.9%	5.66%	0.20
SLSNSolesence, Inc. Common Stock	90.29M	1.28	18.29	40.35%	1.72%	6.21%		1.02
COTYCoty Inc.	2.19B	2.51	-5.70	-3.68%	-9.19%	-14.39%	12.68%	1.07

Profit & Loss

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Sales/Revenue+	2.36B	2.3B	2.23B	2.14B	1.95B	2.09B	2.17B	2.25B	2.25B	2.22B
Revenue Growth %	-2.45%	-2.69%	-2.78%	-4.18%	-8.94%	7.06%	4.04%	3.68%	0.09%	-1.34%
Cost of Goods Sold+	1.2B	1.17B	1.2B	1.17B	1.07B	1.14B	1.29B	1.31B	1.3B	1.3B
COGS % of Revenue	50.89%	51.01%	53.77%	54.85%	54.82%	54.43%	59.46%	58.22%	57.59%	58.4%
Gross Profit+	1.16B	1.13B	1.03B	966.6M	880.9M	951.2M	880.5M	940.8M	955.7M	924.9M
Gross Margin %	49.11%	48.99%	46.23%	45.15%	45.18%	45.57%	40.54%	41.78%	42.41%	41.6%
Gross Profit Growth %	-2.02%	-2.93%	-8.26%	-6.42%	-8.87%	7.98%	-7.43%	6.85%	1.58%	-3.22%
Operating Expenses+	1.16B	1.13B	1.03B	722.8M	704.9M	711.3M	698.2M	713.8M	756.4M	828.3M
OpEx % of Revenue	49.11%	48.99%	46.23%	33.76%	36.15%	34.08%	32.15%	31.7%	33.56%	37.25%
Selling, General & Admin	749.4M	710.8M	688.4M	622.9M	625M	632.7M	627.4M	638.7M	662.1M	671.7M
SG&A % of Revenue	31.73%	30.93%	30.81%	29.09%	32.06%	30.31%	28.89%	28.37%	29.38%	30.21%
Research & Development	71.9M	67.6M	61.1M	53.5M	55.3M	57.8M	55.5M	58.5M	58.4M	57.6M
R&D % of Revenue	3.04%	2.94%	2.73%	2.5%	2.84%	2.77%	2.56%	2.6%	2.59%	2.59%
Other Operating Expenses	338.6M	347.5M	283.4M	46.4M	24.6M	20.8M	15.3M	16.6M	35.9M	99M
Operating Income+	338.6M	347.5M	283.4M	243.8M	176M	239.9M	182.3M	227M	199.3M	96.6M
Operating Margin %	14.34%	15.12%	12.68%	11.39%	9.03%	11.49%	8.39%	10.08%	8.84%	4.34%
Operating Income Growth %	94.49%	2.63%	-18.45%	-13.97%	-27.81%	36.31%	-24.01%	24.52%	-12.2%	-51.53%
EBITDA+	431.2M	441.9M	381M	337.6M	264.8M	327M	272.2M	318.4M	287.3M	185.4M
EBITDA Margin %	18.26%	19.23%	17.05%	15.77%	13.58%	15.67%	12.53%	14.14%	12.75%	8.34%
EBITDA Growth %	49%	2.48%	-13.78%	-11.39%	-21.56%	23.49%	-16.76%	16.97%	-9.77%	-35.47%
D&A (Non-Cash Add-back)	92.6M	94.4M	97.6M	93.8M	88.8M	87.1M	89.9M	91.4M	88M	88.8M
EBIT	291.7M	16.3M	231.8M	-327.7M	148.5M	215M	195.5M	226.2M	197.4M	96.8M
Net Interest Income+	-71.8M	-69.2M	-68M	-62.6M	-61.2M	-67.9M	-71.4M	-78.5M	-76.5M	-73.2M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	71.8M	69.2M	68M	62.6M	61.2M	67.9M	71.4M	78.5M	76.5M	73.2M
Other Income/Expense	-118.7M	-400.4M	-119.6M	-634.1M	-88.7M	-92.8M	-58.2M	-79.3M	-78.4M	-73M
Pretax Income+	219.9M	-52.9M	163.8M	-390.3M	87.3M	147.1M	124.1M	147.7M	120.9M	23.6M
Pretax Margin %	9.31%	-2.3%	7.33%	-18.23%	4.48%	7.05%	5.71%	6.56%	5.36%	1.06%
Income Tax+	41.2M	-58.6M	60.5M	-18.1M	19.7M	29.3M	24.6M	33M	22.3M	-1.8M
Effective Tax Rate %	81.26%	-10.78%	63.06%	95.36%	77.43%	80.08%	80.18%	77.66%	81.56%	107.63%
Net Income+	178.7M	5.7M	103.3M	-372.2M	67.6M	117.8M	99.5M	114.7M	98.6M	25.4M
Net Margin %	7.57%	0.25%	4.62%	-17.38%	3.47%	5.64%	4.58%	5.09%	4.38%	1.14%
Net Income Growth %	164.91%	-96.81%	1712.28%	-460.31%	118.16%	74.26%	-15.53%	15.28%	-14.04%	-74.24%
Net Income (Continuing)	178.7M	5.7M	103.3M	-372.2M	67.6M	117.8M	99.5M	114.7M	98.6M	25.4M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	2.99	0.10	1.90	-6.52	1.24	2.12	1.86	2.21	1.97	0.53
EPS Growth %	167.34%	-96.66%	1800%	-443.16%	119.02%	70.97%	-12.26%	18.82%	-10.86%	-73.1%
EPS (Basic)	3.02	0.10	1.90	-6.52	1.25	2.15	1.87	2.24	1.98	0.53
Diluted Shares Outstanding	59.7M	57.5M	54.5M	54.1M	54.6M	55.2M	53.6M	51.8M	50.1M	47.6M
Basic Shares Outstanding	59.2M	57.3M	54.4M	54.1M	54.3M	54.4M	53.1M	51.2M	49.7M	47.5M
Dividend Payout Ratio	-	-	-	-	-	21.73%	32.76%	27.46%	31.14%	115.35%

Balance Sheet

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Current Assets+	1.45B	1.19B	951.2M	1.04B	983.6M	1.14B	942.2M	962.4M	936M	995.5M
Cash & Short-Term Investments	738.9M	502.9M	266.4M	341.6M	364.7M	479.2M	188.7M	216.4M	209.1M	225.7M
Cash Only	738.9M	502.9M	266.4M	341.6M	364.7M	479.2M	188.7M	216.4M	209.1M	225.7M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	289.8M	241M	239.1M	205.6M	229.8M	230.6M	208.9M	168.8M	164.1M	194.8M
Days Sales Outstanding	44.78	38.27	39.06	35.05	43.02	40.32	35.11	27.36	26.58	31.98
Inventory	309.2M	333.5M	329.5M	357.2M	314.1M	345.7M	449.3M	492.4M	477.3M	484.7M
Days Inventory Outstanding	93.88	103.82	100.1	111.02	107.27	111.06	127.01	137.11	134.22	136.24
Other Current Assets	94.2M	70.1M	60.4M	75M	10.2M	12.9M	25.1M	12.3M	9.1M	11.9M
Total Non-Current Assets+	3.32B	3B	3B	2.4B	2.56B	2.54B	2.77B	2.78B	2.79B	2.76B
Property, Plant & Equipment	486.1M	453.4M	424.1M	396M	414.4M	362.6M	345.5M	337.9M	434.5M	369.3M
Fixed Asset Turnover	4.86x	5.07x	5.27x	5.41x	4.70x	5.76x	6.29x	6.66x	5.19x	6.02x
Goodwill	1.42B	1.45B	1.45B	1.05B	1.16B	1.16B	1.32B	1.33B	1.34B	1.29B
Intangible Assets	1.39B	1.07B	1.1B	912.9M	928.1M	906.4M	996.7M	973.8M	948.5M	921.3M
Long-Term Investments	-255.3M	-181.8M	-176.1M	-101.1M	0	0	0	0	0	0
Other Non-Current Assets	28M	31.6M	28.2M	34.8M	55.1M	107.1M	106.6M	135.2M	73.3M	179.1M
Total Assets+	4.77B	4.19B	3.95B	3.44B	3.54B	3.67B	3.71B	3.74B	3.73B	3.76B
Asset Turnover	0.50x	0.55x	0.57x	0.62x	0.55x	0.57x	0.58x	0.60x	0.60x	0.59x
Asset Growth %	-4.41%	-12.21%	-5.62%	-12.94%	2.88%	3.78%	1.05%	0.74%	-0.26%	0.68%
Total Current Liabilities+	868.2M	524.4M	717M	659.6M	510.5M	536.8M	539.5M	523.4M	563.6M	565.5M
Accounts Payable	196.5M	223.6M	238.4M	222.8M	181.9M	209.5M	228.8M	194.4M	219.3M	219.7M
Days Payables Outstanding	59.66	69.61	72.42	69.25	62.12	67.31	64.68	54.13	61.67	61.75
Short-Term Debt	300.3M	19.4M	193.1M	131.4M	30.2M	26.5M	19M	19.5M	41.2M	44.9M
Deferred Revenue (Current)	0	0	24.3M	1.7M	1.4M	600K	1.1M	0	1.1M	800K
Other Current Liabilities	269.6M	222.5M	214.7M	230.3M	215.1M	132.4M	122.3M	131.9M	209.8M	226.7M
Current Ratio	1.67x	2.26x	1.33x	1.58x	1.93x	2.12x	1.75x	1.84x	1.66x	1.76x
Quick Ratio	1.32x	1.63x	0.87x	1.04x	1.31x	1.47x	0.91x	0.90x	0.81x	0.90x
Cash Conversion Cycle	79	72.48	66.73	76.82	88.17	84.08	97.44	110.34	99.13	106.46
Total Non-Current Liabilities+	2.07B	1.92B	1.49B	1.46B	1.6B	1.55B	1.71B	1.68B	1.58B	1.64B
Long-Term Debt	1.54B	1.53B	1.1B	1.1B	1.24B	1.23B	1.39B	1.36B	1.27B	1.44B
Capital Lease Obligations	0	0	0	0	34.6M	46.9M	41.5M	53.9M	69.8M	57.1M
Deferred Tax Liabilities	255.3M	181.8M	176.1M	102.8M	124.3M	129M	140.4M	136.4M	149.8M	130M
Other Non-Current Liabilities	274.8M	397.3M	387.9M	258.9M	200.7M	143.4M	133.2M	125.8M	88.6M	10.2M
Total Liabilities	2.94B	2.45B	2.21B	2.12B	2.11B	2.09B	2.25B	2.2B	2.15B	2.2B
Total Debt+	1.84B	1.54B	1.3B	1.23B	1.3B	1.32B	1.46B	1.45B	1.39B	1.54B
Net Debt	1.11B	1.04B	1.03B	887.6M	938M	839.4M	1.27B	1.23B	1.18B	1.32B
Debt / Equity	1.01x	0.89x	0.74x	0.93x	0.91x	0.83x	1.00x	0.94x	0.87x	0.99x
Debt / EBITDA	4.28x	3.50x	3.40x	3.64x	4.92x	4.03x	5.37x	4.55x	4.82x	8.32x
Net Debt / EBITDA	2.56x	2.36x	2.70x	2.63x	3.54x	2.57x	4.67x	3.87x	4.10x	7.10x
Interest Coverage	4.72x	5.02x	4.17x	3.89x	2.88x	3.53x	2.55x	2.89x	2.61x	1.32x
Total Equity+	1.83B	1.74B	1.74B	1.32B	1.43B	1.58B	1.47B	1.54B	1.58B	1.55B
Equity Growth %	-1.88%	-4.77%	0.17%	-24.18%	8.32%	10.57%	-7.4%	5%	2.83%	-1.96%
Book Value per Share	30.64	30.29	32.01	24.45	26.24	28.70	27.37	29.74	31.62	32.63
Total Shareholders' Equity	1.83B	1.74B	1.74B	1.32B	1.43B	1.58B	1.47B	1.54B	1.58B	1.55B
Common Stock	700K	700K	700K	700K	700K	700K	700K	700K	700K	700K
Retained Earnings	946M	952.9M	1.08B	734.1M	782.4M	865.7M	939.1M	1.02B	1.09B	1.09B
Treasury Stock	-563M	-703.9M	-819.2M	-803.8M	-790.4M	-776.3M	-860.9M	-906.1M	-937.9M	-1B
Accumulated OCI	-197.2M	-131.4M	-148.3M	-235.9M	-191.6M	-136.9M	-216.1M	-170M	-154.8M	-109.8M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Cash from Operations+	176.4M	296.2M	264.7M	190.6M	232.6M	229M	102M	216.1M	231M	118.4M
Operating CF Margin %	7.47%	12.89%	11.85%	8.9%	11.93%	10.97%	4.7%	9.6%	10.25%	5.32%
Operating CF Growth %	18.55%	67.91%	-10.63%	-27.99%	22.04%	-1.55%	-55.46%	111.86%	6.89%	-48.74%
Net Income	178.7M	5.7M	103.3M	-352.9M	67.6M	117.8M	99.5M	114.7M	98.6M	25.4M
Depreciation & Amortization	92.6M	94.4M	97.6M	93.8M	88.8M	87.1M	89.9M	91.4M	88M	88.8M
Stock-Based Compensation	25.6M	22.2M	17M	17.8M	19.2M	27.3M	23.8M	27.5M	26.5M	24.5M
Deferred Taxes	7.8M	-87.4M	2.3M	-57.9M	-2.9M	9.6M	-13.7M	-4.5M	-9.6M	-21.7M
Other Non-Cash Items	-109.8M	282M	43.4M	537.3M	16.7M	15.2M	-15.4M	-18M	-20.1M	27.2M
Working Capital Changes	-18.5M	-20.7M	1.1M	-47.5M	43.2M	-28M	-82.1M	5M	47.6M	-25.8M
Change in Receivables	23.3M	41.4M	-5.4M	-1.9M	66.3M	3.7M	-6.6M	31M	-7.3M	-15.3M
Change in Inventory	28.2M	-15.5M	-12.3M	-35M	37.1M	-28.8M	-111.3M	-32.4M	19.7M	100K
Change in Payables	-29.3M	23.7M	11.5M	-15.1M	-42.9M	24.3M	29.3M	-30.2M	17M	3.3M
Cash from Investing+	-69.5M	-84.6M	-128.5M	-45.5M	-196.4M	-48.7M	-355.4M	-50.5M	-62.4M	-72.9M
Capital Expenditures	-69.5M	-69M	-62M	-58M	-47.7M	-56.8M	-56.4M	-49.5M	-56.5M	-77M
CapEx % of Revenue	2.94%	3%	2.77%	2.71%	2.45%	2.72%	2.6%	2.2%	2.51%	3.46%
Acquisitions	0	-34M	-71.2M	4.1M	-137.8M	7.2M	-304.4M	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	18.4M	4.7M	8.4M	2.9M	900K	5.4M	-1M	-5.9M	4.1M
Cash from Financing+	-83M	-460.6M	-375.2M	-63.8M	-18.7M	-65.4M	-17.6M	-146.5M	-179.4M	-30M
Debt Issued (Net)	114.2M	-295M	-247.7M	-69.2M	9.8M	-21.9M	151.1M	-33M	-83.8M	111.5M
Equity Issued (Net)	-1000K	-1000K	-1000K	0	0	-1000K	-1000K	-1000K	-1000K	-1000K
Dividends Paid	0	0	0	0	0	-25.6M	-32.6M	-31.5M	-30.7M	-29.3M
Share Repurchases	-196.6M	-165.4M	-124.4M	-3M	0	-9.2M	-125.3M	-75.2M	-58.5M	-90.2M
Other Financing	9.8M	-200K	-7.5M	5.4M	-28.5M	-8.7M	-10.8M	-6.8M	-6.4M	-22M
Net Change in Cash	26.8M	-236M	-236.5M	75.2M	23.1M	114.5M	-290.5M	27.7M	-7.3M	16.6M
Free Cash Flow+	106.9M	227.2M	202.7M	132.6M	184.9M	172.2M	45.6M	166.6M	174.5M	41.4M
FCF Margin %	4.53%	9.89%	9.07%	6.19%	9.48%	8.25%	2.1%	7.4%	7.74%	1.86%
FCF Growth %	116.4%	112.54%	-10.78%	-34.58%	39.44%	-6.87%	-73.52%	265.35%	4.74%	-76.28%
FCF per Share	1.79	3.95	3.72	2.45	3.39	3.12	0.85	3.22	3.48	0.87
FCF Conversion (FCF/Net Income)	0.99x	51.96x	2.56x	-0.51x	3.44x	1.94x	1.03x	1.88x	2.34x	4.66x
Interest Paid	71.3M	66.4M	66.6M	60.6M	56.1M	0	68.4M	74.3M	62.8M	0
Taxes Paid	28.3M	14.4M	22M	58M	24.6M	25.4M	23.8M	45.8M	33.5M	25.5M

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	9.68%	0.32%	5.93%	-24.27%	4.91%	7.81%	6.52%	7.63%	6.31%	1.62%
Return on Invested Capital (ROIC)	8.74%	9.12%	7.65%	7.34%	5.76%	7.51%	5.3%	6.18%	5.4%	2.57%
Gross Margin	49.11%	48.99%	46.23%	45.15%	45.18%	45.57%	40.54%	41.78%	42.41%	41.6%
Net Margin	7.57%	0.25%	4.62%	-17.38%	3.47%	5.64%	4.58%	5.09%	4.38%	1.14%
Debt / Equity	1.01x	0.89x	0.74x	0.93x	0.91x	0.83x	1.00x	0.94x	0.87x	0.99x
Interest Coverage	4.72x	5.02x	4.17x	3.89x	2.88x	3.53x	2.55x	2.89x	2.61x	1.32x
FCF Conversion	0.99x	51.96x	2.56x	-0.51x	3.44x	1.94x	1.03x	1.88x	2.34x	4.66x
Revenue Growth	-2.45%	-2.69%	-2.78%	-4.18%	-8.94%	7.06%	4.04%	3.68%	0.09%	-1.34%

Edgewell Personal Care Company (EPC) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare EPC vs Peers

vs CL

vs EL

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Edgewell Personal Care Company (EPC) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare EPC vs Peers

vs CL

vs EL

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios